Serum prostate-specific antigen hemodilution among obese men undergoing screening in the prostate, lung, colorectal, and ovarian cancer screening trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 3, 2009, Pages 748-751

  Grubb III, Robert L ^a   Black, Amanda ^b   Izmirlian, Grant ^b   Hickey, Thomas P ^c   Pinsky, Paul F ^b   Mabie, Jerome E ^c   Riley, Thomas L ^c   Ragard, Lawrence R ^d   Prorok, Philip C ^b   Berg, Christine D ^b   Crawford, E David ^e   Church, Timothy R ^f   Andriole Jr , Gerald L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d WESTAT   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER SCREENING; CLINICAL TRIAL; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; DIGITAL RECTAL EXAMINATION; FEMALE; HEMODILUTION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVARY CANCER; PLASMA VOLUME; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; ANALYSIS OF VARIANCE; BLOOD; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; OBESITY; PROSTATE TUMOR; QUESTIONNAIRE;

AGED; ANALYSIS OF VARIANCE; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; HEMODILUTION; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OBESITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES;

EID: 64549162443     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0938     Document Type: Article

References (24)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
3. MacInnis RJ, English DR. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006;17:989-1003. (Pubitemid 44290764)
4. Freedland SJ, Aronson WJ, Kane CJ, et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 2004;22:446-453 (Pubitemid 41079773)
5. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638 (Pubitemid 36459468)
6. Freedland SJ, Platz EA. Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 2007;29:88-97. (Pubitemid 47229642)
7. Skolarus TA, Wolin KY, Grubb RL III. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer. Nat Clin Pract Urol 2007;4:605-614 (Pubitemid 350130557)
8. Baillargeon J, Pollock BH, Kristal AR, et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 2005;103:1092-1095 (Pubitemid 40270087)
9. Werny DM, Thompson T, Saraiya M, et al. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev 2007;16:70-76
10. Freedland SJ, Platz EA, Presti JC, Jr., et al. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol 2006;175:500-4; discussion 504. (Pubitemid 43067337)
11. Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 2001;10:345-353 (Pubitemid 32703219)
12. Banez LL, Hamilton RJ, Partin AW, et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007;298:2275-2280 (Pubitemid 350146217)
13. Rundle A, Neugut AI. Obesity and screening PSA levels among men undergoing an annual physical exam. Prostate 2008;68:373-380
14. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21:273-309S.
15. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-871
16. Boer P. Estimated lean body mass as an index for normalization of body fluid volumes in humans. Am J Physiol 1984;247:F632-6. (Pubitemid 15209771)
17. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1-452.
18. Platz EA, Giovannucci E. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol 2004;92:237-253 (Pubitemid 40128245)
19. Xue W, Coetzee GA, Ross RK, et al. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2001;10:575-579 (Pubitemid 32703190)
20. McAdams MA, Van Dam RM, Hu FB. Comparison of self-reported and measured BMI as correlates of disease markers in US adults. Obesity 2007;15:188-196 (Pubitemid 46219799)
21. du Raan H, Lotter MG, Harris GW, et al. Measurement of plasma volume using 99Tc(m)-labelled DMP-HSA. Nucl Med Commun 2000;21:539-544
22. Ockelford PA, Lowe G, Johns AS, Berry EW. Comparison of methods of plasma volume determination for dose calculation of factor VIII in patients with classic haemophilia. N Z Med J 1986;99:116-119 (Pubitemid 16108417)
23. Henderson RJ, Eastham JA, Culkin DJ, et al. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer. J Natl Cancer Inst 1997;89:134-138 (Pubitemid 27034789)
24. Gelmann EP, Chia D, Pinsky PF, et al. Relationship of demographic and clinical factors to free and total prostate-specific antigen. Urology 2001;58:561-566 (Pubitemid 32904498)